COMMUNIQUÉS West-GlobeNewswire

Apricus Biosciences Receives Complete Response Letter from FDA for Vitaros™
16/02/2018
SAN DIEGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI ), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the U.S. Food and Drug [...]
RSNA17 AI Bone Age Challenge Champion, 16 Bit, Offers Award-Winning Algorithm on EnvoyAI Platform Free for Research Use
16/02/2018
CAMBRIDGE, Mass., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Artificial intelligence platform provider EnvoyAI ( www.envoyai.com ) today announced a new partnership with 16 Bit ( www.16bit.ai ), the winner of the Radiological [...]
Notice of Nexstim Plc 2017 Full Year Results
16/02/2018
Company announcement, Helsinki, 16 February 2018, at 9 am Notice of Nexstim Plc 2017 Full Year Results Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), a medical technology company developing and marketing [...]
Immunicum AB (publ) Year-End Report (October - December 2017) Corporate Update and Outlook
16/02/2018
Press Release 16 February 2018 Immunicum AB (publ) Year-End Report (October - December 2017) Corporate Update and Outlook Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming cancer [...]
Photocure Announces U.S. FDA Approval of New Indications for Blue Light Cystoscopy with Cysview®
16/02/2018
Oslo, Norway, February 16, 2018 Photocure ASA (OSE: PHO), announced today that the U.S. Food and Drug Administration (FDA) approved its supplemental new drug application (sNDA) to extend the indication for Blue Light [...]
ESPERITE (ESP): EUR 500,000 of new funding provided by European Select Growth Opportunities Fund until March 2, 2018.
16/02/2018
Continuation of support to Esperite's strategy, commercial activities and development of innovative technologies in the field of genetics and regenerative medicines Amsterdam, The Netherlands - 16 February 2018 As of [...]
ABLYNX ANNOUNCES OPTION EXERCISE BY SANOFI FOR TWO ADDITIONAL MULTI-SPECIFIC NANOBODY PRODUCT CANDIDATES
16/02/2018
REGULATED INFORMATION - INSIDE INFORMATION GHENT, Belgium, 16 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced that Sanofi has exercised its option to license two additional target [...]
ALK’s partner, Torii, gains paediatric approval for the house dust mite SLIT-tablet in Japan
16/02/2018
Copenhagen, 2018-02-16 07:00 CET (GLOBE NEWSWIRE) -- ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) today announced that its partner for Japan, Torii, has gained approval from the Japanese Ministry of Health, Labour and [...]
Amicus Therapeutics Prices Underwritten Offering of Common Stock
16/02/2018
CRANBURY, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced the pricing of an underwritten offering of 19,354,839 shares of its common stock at $15.50 per share. The gross [...]
IDC Announce Appointment of Auditor and Resignation of the Director
15/02/2018
CALGARY, Alberta, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Ima ging Dynamics Company, Ltd . ("IDC" or the "Company") (TSX Venture:IDL) is pleased to announce today that its board of directors (the “Board”) has approved a [...]
Athenex實現轉移性乳腺癌三期臨床試驗受試者招募目標，計劃在2018年第三季度進行第二次中期分析
15/02/2018
美國紐約州水牛城, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. ﹙Nasdaq:ATNX﹚是一間環球性的生物醫藥公司，致力於發掘、研發及商業化新型療法以治療癌症和相關病症。今日，Athenex, Inc.公布公司已實現受試者招募目標，讓公司得以在2018年第三季度對Oraxol KX-ORAX-001三期臨床試驗進行第二次中期分析。 Oraxol是一種治療癌症的創新方法， [...]
Sienna Senior Living Inc. Reports 2017 Fourth Quarter Financial Results
15/02/2018
MARKHAM, Ontario, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) today announced its financial results for the year ended December 31, 2017. The Audited [...]
Xeris Pharmaceuticals Achieves Phase 3 Milestones of its Ready-to-Use Glucagon Rescue Pen for the Treatment of Severe Hypoglycemia
15/02/2018
Chicago, IL, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and [...]
Xtant Medical Announces Compliance with NYSE American
15/02/2018
Reports Pro Forma Stockholders’ Equity of approximately $47.4M as of 2/15/18 Xtant has regained compliance with the NYSE American listing standards BELGRADE, Mont., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Xtant™ Medical [...]
Sol-Gel’s Phase 2 Data on TWIN and VERED to be Presented at the 2018 American Academy of Dermatology Annual Meeting
15/02/2018
NESS ZIONA, Israel, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (“Sol-Gel”) (NASDAQ: SLGL ), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and [...]
Progenics Pharmaceuticals to Present at the 2018 RBC Capital Markets Global Healthcare Conference
15/02/2018
NEW YORK, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, [...]
Portola Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on Wednesday, February 28, 2018
15/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) today announced that it will host a webcast and conference call to discuss the Company’s financial results [...]
Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017
15/02/2018
TUCSON, Ariz., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary full-year 2017 financial results including the quarter ending December 31, 2017. The company reported revenue for [...]
Akcea Announces FDA Advisory Committee Meeting to Review Volanesorsen as a Treatment for Familial Chylomicronemia Syndrome
15/02/2018
CAMBRIDGE, Mass., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious [...]

Pages